IDH1 Gene Sequence Analysis
Definition
IDH1 gene mutations are seen in 6 to 10% of AML patients and in more than 70% of low-grade gliomas. The mutant IDH1 enzyme produces the oncometabolite 2-hydroxyglutarate, leading to DNA/histone hypermethylation and a block in myeloid differentiation.
Gene/region examined
IDH1 exon 4
Method
DNA analysis
Accepted sample types
Bone marrow (EDTA), FFPE
Description
AML prognosis.
Inheritance
This is somatic, a mutation acquired in tumor tissue in both AML and glioma.